160 Health International (HKSE:02656) Total Equity: HK$258.6 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02656 160 Health International Ltd HKSE:02656
8 GF Score
Price HK$9.64
! 5 Warning Signs
View Full Analysis

What is 160 Health International Total Equity?

160 Health International HKSE:02656 -2.87% 8 Total Equity is HK$258.6 Mil as of Dec. 2025. GuruFocus rates HKSE:02656 with a GF Score™ of 8/100. The stock has 5 warning signs investors should review.

160 Health International's total equity for the quarter that ended in Dec. 2025 was HK$258.6 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

160 Health International Total Equity Historical Data

* Premium members only.

The historical data trend for 160 Health International's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

160 Health International Total Equity Chart

160 Health International Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Total Equity
-438.24 -44.36 -94.49 258.63

160 Health International Semi-Annual Data
Dec22 Dec23 Jun24 Dec24 Jun25 Dec25
Total Equity Get a 7-Day Free Trial -44.36 0.00 -94.49 -107.33 258.63
HKSE:02656
8GF Score
160 Health International Ltd HKSE:02656
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

160 Health International Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

160 Health International's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=839.51-580.879
=258.6

160 Health International's Total Equity for the quarter that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=839.51-580.879
=258.6

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of HK$258.6 Mil mean?
160 Health International (HKSE:02656) has a Total Equity of HK$258.6 Mil as of Dec. 2025. The total amount of equity as record on a company's balance sheet. View historical data for 160 Health International and its competitors.
Is 160 Health International's Total Equity too high?
160 Health International's current Total Equity is HK$258.6 Mil. Overall, 160 Health International has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does 160 Health International's Total Equity compare to MCK and COR?
160 Health International's Total Equity of HK$258.6 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Distribution company?
A good Total Equity depends on the Medical Distribution industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for 160 Health International and its competitors. 160 Health International's current Total Equity is HK$258.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 160 Health International stock overvalued right now?
160 Health International (HKSE:02656) has a current Total Equity of HK$258.6 Mil. The current Total Equity is HK$258.6 Mil. 160 Health International's overall GF Score™ is 8/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For 160 Health International (HKSE:02656), the current Total Equity is HK$258.6 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

160 Health International Business Description

Address 4078 Dongbin Road, Nanshan Street, 9th, 11th - 12th Floor, Building 2, Yongxin Times Square, Nanshan District, Shenzhen, CHN, 518052
160 Health International Ltd is an experienced pharmaceutical and healthcare product wholesaler and a digital healthcare integrated service provider in China. The company offers a wide assortment of high-quality pharmaceutical and healthcare products under both wholesale and retail models, to address a spectrum of customer needs. In addition, through its online healthcare and wellness service platform, Healthcare 160 Platform. It also provide digital healthcare and wellness solutions, empowering each Platform Participants, including business customers, medical and healthcare institutions, medical professionals, individual users, and third-party merchants, throughout the healthcare value chain and driving the digital transformation of China's healthcare and wellness industry.
8GF Score

Get the complete analysis for HKSE:02656

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$9.64
Price